» Articles » PMID: 18424475

Sensitivity of Between-study Heterogeneity in Meta-analysis: Proposed Metrics and Empirical Evaluation

Overview
Journal Int J Epidemiol
Specialty Public Health
Date 2008 Apr 22
PMID 18424475
Citations 459
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Several approaches are available for evaluating heterogeneity in meta-analysis. Sensitivity analyses are often used, but these are often implemented in various non-standardized ways.

Methods: We developed and implemented sequential and combinatorial algorithms that evaluate the change in between-study heterogeneity as one or more studies are excluded from the calculations. The algorithms exclude studies aiming to achieve either the maximum or the minimum final I(2) below a desired pre-set threshold. We applied these algorithms in databases of meta-analyses of binary outcome and >/=4 studies from Cochrane Database of Systematic Reviews (Issue 4, 2005, n = 1011) and meta-analyses of genetic associations (n = 50). Two I(2) thresholds were used (50% and 25%).

Results: Both algorithms have succeeded in achieving the pre-specified final I(2) thresholds. Differences in the number of excluded studies varied from 0% to 6% depending on the database and the heterogeneity threshold, while it was common to exclude different specific studies. Among meta-analyses with initial I(2) > 50%, in the large majority [19 (90.5%) and 208 (85.9%) in genetic and Cochrane meta-analyses, respectively] exclusion of one or two studies sufficed to decrease I(2) < 50%. Similarly, among meta-analyses with initial I(2) > 25%, in most cases [16 (57.1%) and 382 (81.3%), respectively) exclusion of one or two studies sufficed to decrease heterogeneity even <25%. The number of excluded studies correlated modestly with initial estimated I(2) (correlation coefficients 0.52-0.68 depending on algorithm used).

Conclusions: The proposed algorithms can be routinely applied in meta-analyses as standardized sensitivity analyses for heterogeneity. Caution is needed evaluating post hoc which specific studies are responsible for the heterogeneity.

Citing Articles

The triglyceride-glucose index is associated with a higher risk of hypertension: evidence from a cross-sectional study of Chinese adults and meta-analysis of epidemiology studies.

Ren X, Chen M, Lian L, Xia H, Chen W, Ge S Front Endocrinol (Lausanne). 2025; 16:1516328.

PMID: 40065994 PMC: 11891255. DOI: 10.3389/fendo.2025.1516328.


Temporomandibular disorder prevalence in malocclusion patients: a meta-analysis.

Huang L, Xu Y, Xiao Z, Liu Y, Luo F Head Face Med. 2025; 21(1):13.

PMID: 40011997 PMC: 11863559. DOI: 10.1186/s13005-025-00490-0.


Efficacy of mobile health interventions in the conservative management of chronic low back pain in low- and middle-income countries: a systematic review, meta-analysis, and trial sequential analysis.

Rani B, Gupta M, Ganesh V, Sharma R, Bhatia A, Ghai B Pain Rep. 2025; 10(2):e1242.

PMID: 39957758 PMC: 11826050. DOI: 10.1097/PR9.0000000000001242.


Triglyceride-glucose-body mass index and the incidence of cardiovascular diseases: a meta-analysis of cohort studies.

Rao X, Xin Z, Yu Q, Feng L, Shi Y, Tang T Cardiovasc Diabetol. 2025; 24(1):34.

PMID: 39844258 PMC: 11756031. DOI: 10.1186/s12933-025-02584-0.


Pooled prevalence and subgroup variations of Tetralogy of Fallot among children and adolescents with congenital heart defect in Sub-Saharan Africa: A systematic review and meta-analysis.

Geleta B, Mulu A PLoS One. 2025; 20(1):e0311686.

PMID: 39823394 PMC: 11741593. DOI: 10.1371/journal.pone.0311686.


References
1.
Lau J, Ioannidis J, Schmid C . Summing up evidence: one answer is not always enough. Lancet. 1998; 351(9096):123-7. DOI: 10.1016/S0140-6736(97)08468-7. View

2.
Ghersi D, Wilcken N, Simes J, Donoghue E . Taxane containing regimens for metastatic breast cancer. Cochrane Database Syst Rev. 2005; (2):CD003366. DOI: 10.1002/14651858.CD003366.pub2. View

3.
Juni P, Altman D, Egger M . Systematic reviews in health care: Assessing the quality of controlled clinical trials. BMJ. 2001; 323(7303):42-6. PMC: 1120670. DOI: 10.1136/bmj.323.7303.42. View

4.
Baujat B, Mahe C, Pignon J, Hill C . A graphical method for exploring heterogeneity in meta-analyses: application to a meta-analysis of 65 trials. Stat Med. 2002; 21(18):2641-52. DOI: 10.1002/sim.1221. View

5.
Song F, Sheldon T, Sutton A, Abrams K, Jones D . Methods for exploring heterogeneity in meta-analysis. Eval Health Prof. 2001; 24(2):126-51. DOI: 10.1177/016327870102400203. View